Pfizer CEO rules out generic Covid drug Paxlovid for China
Pfizer Inc is not in talks with Chinese authorities to licence a generic version of its Covid-19 treatment Paxlovid for use ...
Pfizer Inc is not in talks with Chinese authorities to licence a generic version of its Covid-19 treatment Paxlovid for use ...
Moderna sued Pfizer and its German partner BioNTech on Friday (Aug 26 for patent infringement in the development of the ...
Pfizer Inc and BioNTech's vaccine was 73.2 per cent effective in preventing Covid-19 among children aged six months through four ...
The following is a summary of some recent studies on Covid-19. They include research that warrants further study to corroborate ...
Pfizer Inc will make all of its patented medicines including Covid-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available ...
More than 2.8 million courses of Pfizer Inc’s Covid-19 oral antiviral treatment Paxlovid have been made available at pharmacies around ...
Covid-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many ...
CHICAGO — Additional reports of patients with long covid who were helped by Pfizer Inc's oral antiviral treatment Paxlovid offer fresh ...
Pfizer Inc on Friday said a large trial found that its Covid-19 oral antiviral treatment Paxlovid was not effective at preventing ...
35 generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective Covid-19 oral antiviral Paxlovid to supply ...
© 2020 By Khmer Daily News